Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 62.83M
March 31, 2026 62.16M
December 31, 2025 61.76M
September 30, 2025 53.00M
June 30, 2025 52.82M
March 31, 2025 52.75M
December 31, 2024 52.73M
September 30, 2024 52.62M
June 30, 2024 52.61M
March 31, 2024 52.52M
December 31, 2023 52.51M
September 30, 2023 52.47M
June 30, 2023 52.45M
March 31, 2023 52.34M
December 31, 2022 52.33M
September 30, 2022 52.30M
June 30, 2022 52.02M
Date Value
March 31, 2022 51.94M
December 31, 2021 51.83M
September 30, 2021 51.70M
June 30, 2021 51.43M
March 31, 2021 51.23M
December 31, 2020 51.11M
September 30, 2020 44.76M
June 30, 2020 44.67M
March 31, 2020 44.45M
December 31, 2019 44.41M
September 30, 2019 37.01M
June 30, 2019 36.93M
March 31, 2019 36.91M
December 31, 2018 36.83M
September 30, 2018 36.83M
March 31, 2018 36.83M
December 31, 2017 36.72M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 103.40M
AbbVie, Inc. 1.767B
Mirum Pharmaceuticals, Inc. 64.75M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M